{"transactions":[{"id":2900911,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T21:00:12.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":27000,"derivative":{"exercise_price":4.07,"expiration_date":"2025-04-17","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-21-004769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919121004769/doc4.xml","form_type":"4"}},{"id":2900910,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T21:00:12.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.84,"expiration_date":"2023-11-03","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-21-004769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919121004769/doc4.xml","form_type":"4"}},{"id":2900909,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2021-01-21T21:00:12.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":25000,"price":69,"value":1725000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-004769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919121004769/doc4.xml","form_type":"4"}},{"id":2900908,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2021-01-21T21:00:12.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":23000,"price":4.07,"value":93610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-21-004769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919121004769/doc4.xml","form_type":"4"}},{"id":2900907,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2021-01-21T21:00:12.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":2000,"price":0.84,"value":1680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001209191-21-004769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919121004769/doc4.xml","form_type":"4"}},{"id":2933184,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T19:00:11.000Z","date":"2020-12-22","kind":"exercise","acquired":false,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":2000,"derivative":{"exercise_price":0.84,"expiration_date":"2023-11-03","underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001209191-20-065104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120065104/doc4.xml","form_type":"4"}},{"id":2933183,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-12-23T19:00:11.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":20486,"price":64.06,"value":1312333.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $63.79 to 64.58, inclusive."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-065104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120065104/doc4.xml","form_type":"4"}},{"id":2933182,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-12-23T19:00:11.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":36514,"price":63.52,"value":2319369.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $62.79 to 63.785, inclusive.   The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":30486,"source":{"system":"sec-edgar","filing":"0001209191-20-065104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120065104/doc4.xml","form_type":"4"}},{"id":2933181,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-12-23T19:00:11.000Z","date":"2020-12-22","kind":"exercise","acquired":true,"shares":57000,"price":0.84,"value":47880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."}],"balance_after":67000,"source":{"system":"sec-edgar","filing":"0001209191-20-065104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120065104/doc4.xml","form_type":"4"}},{"id":2942843,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T21:00:15.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":59000,"derivative":{"exercise_price":0.84,"expiration_date":"2023-11-03","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-063933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120063933/doc4.xml","form_type":"4"}},{"id":2942842,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-12-16T21:00:15.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":40000,"price":59,"value":2360000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-063933","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120063933/doc4.xml","form_type":"4"}},{"id":2942841,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-12-16T21:00:15.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":40000,"price":0.84,"value":33600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-20-063933","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120063933/doc4.xml","form_type":"4"}},{"id":3067741,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T21:00:12.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":99000,"derivative":{"exercise_price":0.84,"expiration_date":"2023-11-03","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001209191-20-045396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120045396/doc4.xml","form_type":"4"}},{"id":3067740,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-08-05T21:00:12.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":1600,"price":37.37,"value":59792.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-045396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120045396/doc4.xml","form_type":"4"}},{"id":3067739,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-08-05T21:00:12.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":1600,"price":0.84,"value":1344.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."}],"balance_after":11600,"source":{"system":"sec-edgar","filing":"0001209191-20-045396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120045396/doc4.xml","form_type":"4"}},{"id":3085035,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-10T20:00:32.000Z","date":"2020-07-09","kind":"exercise","acquired":false,"shares":17400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":100600,"derivative":{"exercise_price":0.84,"expiration_date":"2023-11-03","underlying":"Common Stock","underlying_shares":17400},"source":{"system":"sec-edgar","filing":"0001209191-20-042221","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120042221/doc4.xml","form_type":"4"}},{"id":3085034,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-07-10T20:00:32.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":17400,"price":49,"value":852600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $49.00 to 49.01, inclusive.   The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-042221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120042221/doc4.xml","form_type":"4"}},{"id":3085033,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-07-10T20:00:32.000Z","date":"2020-07-09","kind":"exercise","acquired":true,"shares":17400,"price":0.84,"value":14616.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."}],"balance_after":27400,"source":{"system":"sec-edgar","filing":"0001209191-20-042221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120042221/doc4.xml","form_type":"4"}},{"id":3092374,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T19:00:10.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":118000,"derivative":{"exercise_price":0.84,"expiration_date":"2023-11-03","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-20-040676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120040676/doc4.xml","form_type":"4"}},{"id":3092373,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-07-02T19:00:10.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":1200,"price":48.01,"value":57612.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $47.67 to 48.20, inclusive."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-040676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120040676/doc4.xml","form_type":"4"}},{"id":3092372,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-07-02T19:00:10.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":1800,"price":47.03,"value":84654.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $46.66 to 47.59, inclusive.   The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":11200,"source":{"system":"sec-edgar","filing":"0001209191-20-040676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120040676/doc4.xml","form_type":"4"}},{"id":3092371,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-07-02T19:00:10.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":3000,"price":0.84,"value":2520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-20-040676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120040676/doc4.xml","form_type":"4"}},{"id":3102110,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T20:00:15.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":121000,"derivative":{"exercise_price":0.84,"expiration_date":"2023-11-03","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001209191-20-038660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120038660/doc4.xml","form_type":"4"}},{"id":3102109,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-06-23T20:00:15.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":14694,"price":45.38,"value":666813.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $45.00 to 45.54, inclusive."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-038660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120038660/doc4.xml","form_type":"4"}},{"id":3102108,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-06-23T20:00:15.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":4306,"price":44.66,"value":192305.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $44.08 to 44.99, inclusive.   The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":24694,"source":{"system":"sec-edgar","filing":"0001209191-20-038660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120038660/doc4.xml","form_type":"4"}},{"id":3102107,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations & Program Mana"}}],"security":"Common Stock","published_at":"2020-06-23T20:00:15.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":19000,"price":0.84,"value":15960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020."}],"balance_after":29000,"source":{"system":"sec-edgar","filing":"0001209191-20-038660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120038660/doc4.xml","form_type":"4"}},{"id":3267086,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-18T07:05:18.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":50000,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-009860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120009860/doc4.xml","form_type":"4"}},{"id":3316557,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-07T21:00:11.000Z","date":"2020-01-06","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":140000,"derivative":{"exercise_price":0.84,"expiration_date":"2023-11-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-002419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120002419/doc4.xml","form_type":"4"}},{"id":3316556,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Common Stock","published_at":"2020-01-07T21:00:11.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":60000,"price":29.14,"value":1748400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $28.55 to 29.48, inclusive.   The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-002419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120002419/doc4.xml","form_type":"4"}},{"id":3316555,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Common Stock","published_at":"2020-01-07T21:00:11.000Z","date":"2020-01-06","kind":"exercise","acquired":true,"shares":60000,"price":0.84,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001209191-20-002419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000120919120002419/doc4.xml","form_type":"4"}},{"id":3468376,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr Vice President, Operations"}}],"security":"Common Stock","published_at":"2019-07-03T17:50:36.000Z","date":"2019-07-01","kind":"purchase","acquired":true,"shares":300,"price":20,"value":6000.0,"ownership":{"direct":false,"nature":"By Connor Hill (son)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001572426-19-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000157242619000091/edgar.xml","form_type":"4"}},{"id":3468375,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr Vice President, Operations"}}],"security":"Common Stock","published_at":"2019-07-03T17:50:36.000Z","date":"2019-07-01","kind":"purchase","acquired":true,"shares":400,"price":20,"value":8000.0,"ownership":{"direct":false,"nature":"By Brandon Hill (son)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001572426-19-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000157242619000091/edgar.xml","form_type":"4"}},{"id":3468374,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr Vice President, Operations"}}],"security":"Common Stock","published_at":"2019-07-03T17:50:36.000Z","date":"2019-07-01","kind":"purchase","acquired":true,"shares":500,"price":20,"value":10000.0,"ownership":{"direct":false,"nature":"By Ryan Hill (son)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001572426-19-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000157242619000091/edgar.xml","form_type":"4"}},{"id":3468373,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":143620,"kind":"person","name":"HILL NANCY LOUISE","position":1,"cik":"0001780790","reported_name":"HILL NANCY LOUISE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr Vice President, Operations"}}],"security":"Common Stock","published_at":"2019-07-03T17:50:36.000Z","date":"2019-07-01","kind":"purchase","acquired":true,"shares":10000,"price":20,"value":200000.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001572426-19-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780790/000157242619000091/edgar.xml","form_type":"4"}}]}